ohdsi-questions
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | Last revision Both sides next revision | ||
|
ohdsi-questions [2018/04/14 00:00] rohit |
ohdsi-questions [2018/04/15 12:38] rohit |
||
|---|---|---|---|
| Line 94: | Line 94: | ||
| -Risk Window - 30 days after exposure to statins to 0 days after exposure. | -Risk Window - 30 days after exposure to statins to 0 days after exposure. | ||
| + | ===Question - 14=== | ||
| + | To compare the risk of developing malignancy in patients with moderate to severe rheumatoid arthritis treated with tofacitinib and tumor necrosis factor inhibitors (TNFi). | ||
| + | -Treatment Cohort - Patients with moderate to severe rheumatoid arthritis treated with tofacitinib. | ||
| + | -Comparator Cohort - Patients with moderate to severe rheumatoid arthritis treated with TNFi. | ||
| + | -Outcome - Any type of malignancy. | ||
| More discussion on these question can be seen here at [[http:// | More discussion on these question can be seen here at [[http:// | ||
ohdsi-questions.txt · Last modified: 2018/06/04 20:14 by nigam
Page Tools
